NASD · Healthcare · Biotechnology · Canada
BriaCell Therapeutics Corp is a micro cap company (market value under $300 million) in the Biotechnology industry.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing immunotherapies that activate the body's immune system to combat cancer. The company is advancing Bria-IMT™ combined with an immune checkpoint inhibitor in a pivotal study for metastatic breast cancer under FDA Fast Track Designation. BriaCell also develops Bria-OTS™ as a personalized immunotherapy platform for various cancer types.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the BriaCell Therapeutics Corp stock.
Not valued: We cannot value this company yet.
134 more in this industry show a wider margin of safety.
We do not publish a verdict on BCTX yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.